POLISCOPE
Back to bills
Part ofHealth →

The civic record

Read. Follow. Verify.
Enacted

Alabama expands authorized forms of single-dose epinephrine for public schools and public entities

Original title: Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded

Last action · April 17, 2026: EnactedSponsor: Margie Wilcox

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

Alabama enacts a law updating provisions for epinephrine use, allowing any FDA-approved single-use epinephrine delivery device containing a premeasured dose to be stocked and administered by schools, authorized entities, and students, effective October 1, 2026.

Why it matters

Expands the types of emergency allergy devices schools and public-serving organizations can stock and administer, while establishing civil and criminal liability protections for trained staff, physicians, and entities responding to severe allergic reactions.

Background
  • State laws regarding school medication administration and anaphylaxis preparedness establish protocols for handling severe allergic reactions on public school grounds. context

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

K-12 public school students

Students diagnosed with allergies are permitted to carry and self-administer any FDA-approved single-use epinephrine delivery device while on school property.

Directly affected

Authorized entities

Organized entities such as daycares, restaurants, and sports arenas may acquire and stock epinephrine prescriptions and must submit incident reports following administrations.

Directly affected

Medical practitioners and pharmacists

Authorized to prescribe and dispense epinephrine delivery systems in the name of an authorized entity.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What types of epinephrine devices are now authorized under this law?
The law expands authorization to include any epinephrine delivery system consisting of a single-use device approved by the federal Food and Drug Administration that contains a premeasured dose of epinephrine.
Which non-school locations are permitted to stock epinephrine?
Authorized entities include recreation camps, colleges and universities, day care facilities, youth sport leagues, amusement parks, restaurants, places of employment, and sports arenas.
Are schools and trained staff protected from liability?
Yes, schools, authorized entities, their trained employees, and prescribing medical practitioners or pharmacists are granted civil and criminal immunity from liability for acts or omissions taken in good faith under the section, excluding willful or wanton conduct.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Current status: Became law.

Procedural history

16 actions
  1. Apr 17, 2026HouseEnrolled
    Enacted
  2. Apr 9, 2026HouseEnrolled
    Delivered to Governor
  3. Apr 9, 2026Senate
    Signature Requested
  4. Apr 9, 2026House
    Enrolled
  5. Apr 9, 2026House
    Ready to Enroll
  6. Apr 8, 2026SenateFloor
    Motion to Read a Third Time and Pass - Adopted Roll Call 1271
Show 10 earlier actions
  1. Apr 1, 2026Senate
    Read for the Second Time and placed on the Calendar
  2. Apr 1, 2026SenateCommittee
    Reported Out of Committee Second House
  3. Mar 31, 2026SenateCommittee
    Pending Committee Action in Second House
  4. Mar 31, 2026SenateIntroduced
    Read for the first time and referred to the Senate Committee on Healthcare
  5. Mar 17, 2026HouseFloor
    Motion to Read a Third Time and Pass - Adopted Roll Call 966
  6. Mar 17, 2026House
    Third Reading in House of Origin
  7. Mar 11, 2026House
    Read for the Second Time and placed on the Calendar
  8. Mar 11, 2026HouseCommittee
    Reported Out of Committee House of Origin
  9. Mar 3, 2026HouseCommittee
    Pending Committee Action in House of Origin
  10. Mar 3, 2026HouseIntroduced
    Read for the first time and referred to the House Committee on Health

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift95% confidence

Broadening of Emergency Medical Devices

The legislation shifts statutory language from strict autoinjector requirements to any FDA-approved single-use premeasured delivery system.

Connected Entities

State Board of Nursing, Food and Drug Administration, State Board Committee of Public Health and 3 more
OrganizationState Board of Nursing“Co-administers medication curriculum and training standards”Map →
OrganizationFood and Drug Administration“Approves single-use epinephrine devices”Map →
OrganizationState Board Committee of Public Health“Establishes storage requirements and adopts rules”Map →
OrganizationState Department of Education“Develops anaphylaxis preparedness program and medication curriculum”Map →
OrganizationAlabama State Board of Pharmacy“Provides guidance on anaphylaxis preparedness program”Map →
OrganizationDepartment of Public Health“Approves training entities and receives incident reports”Map →

Sources

Open source document

alison.legislature.state.al.us

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz25
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record